PharmaBoardroom

Kazim Dinç – Chairman of the Board, SURDER, Turkey

Kazim Dinç, chairman of the board of SURDER and former Minister of Health of Turkey, offers his insights into the Turkish OTC and health products…

Tae-Han Kim – President & CEO, Samsung Biologics,…

In an exclusive interview, Tae-Han Kim, president and CEO of Samsung Biologics, documents his strategy for expanding Samsung’s operations into…

Wong Kin Sang – Country Manager, Lundbeck Malaysia

Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in Malaysia and the important work…

Turkish Pharma: Crisis-Proof?

Despite the sharp decline in the Turkish lira’s value, the general mood among pharmaceutical executives in Turkey is positive. Rather than being…

Dukgeun Ahn – Associate Dean, Graduate School of…

Professor Dukgeun Ahn of Seoul National University, trade policy advisor to the Ministry of Health offers his insights into the current policies…

Hyzan Mohd Yusof – CEO, OSA Technology, Malaysia

Dr Hyzan Mohd Yusof, CEO at OSA Technology, tells the story of how he founded the company to address Malaysia’s unmet needs in medical devices as…

Fernando Álvarez – Director General Iberia, Allergan,…

Fernando Álvarez, director general of Allergan Iberia, highlights the market’s shift towards more holistic innovation and the company’s main…

The Challenges of Technology Adoption in Healthcare

Mohamed is a passionate Blockchain enthusiast who is committed to helping grow the Blockchain ecosystem around the world. Here he talks about…

Biosimilars in Malaysia: Bridging the Middle East and ASEAN

How Malaysia is setting itself up to provide biosimilars across the Islamic world as well as Asia. Inno Bio Ventures, a Malaysian…

Top Causes of Death in Spain

Although death rates due to cardiovascular diseases in Spain are among the lowest in the EU, they represent the main cause of death in Spain,…

Which Pharma Companies are Helping the Poor Get Access To…

There are around 2 billion people in the world that do not have access to the medicines they need. This week the 2018 Access to Medicine Index was…

Ramli Zainal – Director, NPRA, Malaysia

Dr Ramli Zainal, the director at National Pharmaceutical Regulatory Agency (NPRA), expresses the continuous work of NPRA to build a strong regulatory…

Tagged with